Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as a perioperative therapy for ...

A new drug developed at UC Davis Health could provide a safer and more effective option for bladder cancer patients, reducing chemotherapy toxicity and potentially limiting the need for bladder ...

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of ...

Urological surgeons in Nigeria are raising alarms about the increasing number of bladder and testicular cancer cases, a ...

This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced positive topline results from an interim analysis of the Phase 3 EV-304 ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

General childhood infectious virus, called as BK virus may drive bladder cancer by being dormant in kidneys, providing new ...

A VIRUS that most people pick up in childhood triggered deadly bladder cancer in dad-of-two Tim Tavender. The 51-year-old got a BK virus infection in 2015, which left him feeling like he was ...